News & Events

In this section

NOTOCORD User Group Meeting Voted a Great Success by Delegates

Instem Reports Successful NOTOCORD User Meeting; Featuring 2 Full Days of Presentations, 1:1 Advice Clinics and Networking

CONSHOHOCKEN, PA -  February 6, 2017 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the 2017 NOTOCORD User Group Meeting has been deemed a very successful event by clients.

The meeting, which was held at the Pavillon Henri IV Hotel, Saint-Germain-En-Laye, France on January 26th & 27th, provided 2 full days of presentations, 1:1 Advice Clinics and a lively networking and social program.

The meeting was the first NOTOCORD user event since the company was acquired by Instem in September last year and forms part of Instem’s overarching Customer Involvement Program (CIP). The CIP provides opportunities for Instem clients across the globe to hear the latest news on product strategy, gain in-depth knowledge of Instem’s products and services, help shape and influence product development and become more engaged with key industry initiatives such as SEND.

The agenda featured presentations from the Instem and NOTOCORD team, alongside excellent guest speakers from organizations including Sanofi, Orion Corporation, Aptuit, Biotrial, Janssen Pharmaceuticals, Pluriomics and Inria. Additionally the meeting included a “Hardware Manufacturers Showcase”, giving a platform for NOTOCORD’s hardware partners to demonstrate their capabilities.

The conference covered a range of topics including Data Analysis with NOTOCORD-hem, NOTOCORD’S flagship software platform for the acquisition, display and analysis of physiological signals; an introduction to NOTOCORD-Sense, a new cloud-based collaborative platform for data acquisition and analysis; and a session on new trends in MEA data analysis.

The conference also featured a very informative SEND (Standard for Exchange of Nonclinical Data) session headed by Lou Ann Kramer, National CDISC SEND Team Leader and VP of Regulatory Solutions at Instem, who outlined the current SEND status and future implications for Safety Pharmacology data.

Gregor Grant, Executive Vice President, Instem said “The conference was a great success, it was very interactive and provided an excellent opportunity for us to connect with a core group of key customers. Client feedback both during and following the meeting has been excellent and we look forward to continuing to work with our clients to deliver high-quality and highly reliable solutions that continue to meet and exceed their expectations.”

Reflecting on the meeting, Philippe Zitoun, NOTOCORD founder added “It was fantastic to see such high levels of client engagement, and I am very encouraged to see that our users are already starting to realize the benefits of being part of the Instem group.”

About Instem

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions and consulting services increases client productivity by enhancing product development processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

Press Contacts:

Julie Jones(UK HQ)
+44 (0)1785 825600